Maragasa, Manilyn .
HRN: 22-58-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2023
CEFUROXIME 500MG (TAB)
02/08/2023
02/15/2023
PO
500 Mg
BID
2 Degree RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes